Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells
E Gunsilius, HC Duba, AL Petzer, CM Kahler… - The Lancet, 2000 - thelancet.com
Background Vascular endothelial cells lost from the bloodvessel endothelium through
necrosis or apoptosis must be replaced. We investigated in a leukaemia model whether …
necrosis or apoptosis must be replaced. We investigated in a leukaemia model whether …
Chronic myelogenous leukemia: laboratory diagnosis and monitoring
Rapid developments have occurred both in laboratory medicine and in therapeutic
interventions for the management of patients with chronic myelogenous leukemia (CML) …
interventions for the management of patients with chronic myelogenous leukemia (CML) …
Hepatosplenic γδ-T-cell lymphoma with leukemic course after renal transplantation
M Steurer, R Stauder, K Grünewald, E Gunsilius… - Human pathology, 2002 - Elsevier
Hepatosplenic [gamma][delta]-T-cell lymphoma (HSTCL) is a rare extranodal T-cell non-
Hodgkin's lymphoma (T-NHL) with only 46 well-documented cases in medical literature …
Hodgkin's lymphoma (T-NHL) with only 46 well-documented cases in medical literature …
Assessment of the response to imatinib in chronic myeloid leukemia patients–comparison between the FISH, multiplex and RT‐PCR methods
P Raanani, I Ben‐Bassat, S Gan… - European journal of …, 2004 - Wiley Online Library
Objective: The objective of this study was to evaluate the kinetics of molecular response in
chronic myeloid leukemia (CML) patients treated with imatinib and to compare between the …
chronic myeloid leukemia (CML) patients treated with imatinib and to compare between the …
Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals
B Mohr, M Bornhäuser, U Platzbecker… - Cancer genetics and …, 2001 - Elsevier
Interphase fluorescence in situ hybridization (I-FISH) is frequently used to monitor the
response to therapy in various hematological malignancies. We performed a comparison of I …
response to therapy in various hematological malignancies. We performed a comparison of I …
Qualitative and Quantitative Evaluation of the BCR-ABL Fusion Gene in Chronic Myelogenous Leukemia by Flourescence In Situ Hybridization and Molecular …
S Ozemri Sag, T Yakut, O Gorukmez… - Genetic testing and …, 2015 - liebertpub.com
Aims: Fluorescence in situ hybridization (FISH) and quantitative real-time polymerase chain
reaction (QRT-PCR) were used to diagnose or screen for minimal residual disease (MRD) in …
reaction (QRT-PCR) were used to diagnose or screen for minimal residual disease (MRD) in …
Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01):: a pilot study
T Kühr, W Eisterer, U Apfelbeck, W Linkesch… - Leukemia research, 2000 - Elsevier
The efficacy of continuous oral cytarabine ocfosfate (YNK01)(300 mg/day) in combination
with interferon alpha (IFNα, 5× 106 IU/day) was evaluated in patients with advanced chronic …
with interferon alpha (IFNα, 5× 106 IU/day) was evaluated in patients with advanced chronic …
Hypermetaphase and interphase fluorescence in situ hybridisation for monitoring of remission status in Philadelphia chromosome positive chronic myeloid leukaemia.
HC Duba, W Hilbe, A Mehringer… - International …, 2000 - spandidos-publications.com
Interferon (IFN) alone or in combination with cytostatic drugs, can induce major and durable
cytogenetic remissions in chronic myelogenous leukaemia (CML) patients. Hypermetaphase …
cytogenetic remissions in chronic myelogenous leukaemia (CML) patients. Hypermetaphase …
High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of …
AL Petzer, E Hochenburger, M Haun… - … of Hematotherapy & …, 2002 - liebertpub.com
The objective of this study was to analyze the mobilization kinetics of normal (BCR-ABLneg)
and malignant (BCR-ABLpos) progenitor cells using a new, low toxic, out-patient-based …
and malignant (BCR-ABLpos) progenitor cells using a new, low toxic, out-patient-based …
Kronik Miyelositer Lösemilerde füzyon gen kalitatif ve kantitatif değerlerinin FISH ve moleküler genetik yöntemlerle karşılaştırılması
ŞÖ Sağ - 2010 - search.proquest.com
BCR-ABL pozitif hücrelerin tespitinde, Floresan In Situ Hibridizasyon (FISH) ve Kantitatif
Revers Transkriptaz Polimeraz Zincir Reaksiyonunu (QRT-PCR) içeren moleküler tanısal …
Revers Transkriptaz Polimeraz Zincir Reaksiyonunu (QRT-PCR) içeren moleküler tanısal …